Related Experiment Video
Updated: Jan 20, 2026

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
Antitumor effect of insulin-like growth factor-1 receptor inhibition in head and neck squamous cell carcinoma
Christine E Lehman1, Ashraf A Khalil1,2, Mark J Axelrod1,3
1Department of Otolaryngology-Head and Neck Surgery, University of Virginia Health System, Charlottesville, Virginia, U.S.A.
Objectives:
The insulin-like growth factor-1 receptor (IGF1R) has been implicated in therapeutic resistance in head and neck squamous cell carcinoma (HNSCC), and small molecule tyrosine kinase inhibitors (TKIs) of IGF1R activity may have anticancer activity. Therefore, the relationship between survival and IGF1R expression was assessed for oral cavity (OC) cancer, and the antitumor effects of two IGF1R-TKIs, OSI-906 and BMS-754807, were evaluated in HNSCC cell lines in vitro.
Methods:
Clinical outcome data and tissue microarray immunohistochemistry were used to generate IGF1R expression-specific survival curves. Immunoblot, alamarBlue proliferation assay, trypan blue exclusion viability test, clonogenic assay, flow cytometry, and reverse phase protein array (RPPA) were used to evaluate in vitro responses to IGF1R-TKIs.
Results:
For patients with stage III/IV OCSCC, higher IGF1R expression was associated with poorer overall 5-year survival (P = 0.029). Both BMS-754807 and OSI-906 caused dose-dependent inhibition of IGF1R and Akt phosphorylation and inhibited proliferation; BMS-754807 was more potent than OSI-906. Both drugs reduced HNSCC cell viability; only OSI-906 was able to eliminate all viable cells at 10 μM. The two drugs similarly inhibited clonogenic cell survival. At 1 μM, only BMS-754807 caused a fourfold increase in the basal apoptotic rate. RPPA demonstrated broad effects of both drugs on canonical IGF1R signaling pathways and also inhibition of human epidermal growth factor receptor-3 (HER3), Src, paxillin, and ezrin phosphorylation.
Conclusion:
OSI-906 and BMS-754807 inhibit IGF1R activity in HNSCC cell lines with reduction in prosurvival and proliferative signaling and with concomitant antiproliferative and proapoptotic effects. Such antagonists may have utility as adjuvants to existing therapies for HNSCC.
Level Of Evidence:
NA Laryngoscope, 130:1470-1478, 2020.
Insights
Higher insulin-like growth factor-1 receptor (IGF1R) expression correlates with poorer survival in oral cavity squamous cell carcinoma. Two IGF1R tyrosine kinase inhibitors (TKIs) showed anticancer effects in head and neck squamous cell carcinoma cell lines.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Insulin-like growth factor-1 receptor (IGF1R) signaling is implicated in therapeutic resistance in head and neck squamous cell carcinoma (HNSCC).
- Small molecule tyrosine kinase inhibitors (TKIs) targeting IGF1R activity present a potential therapeutic strategy for HNSCC.
Purpose of the Study:
- To investigate the association between IGF1R expression and survival in oral cavity (OC) cancer.
- To evaluate the in vitro antitumor effects of two IGF1R-TKIs, OSI-906 and BMS-754807, on HNSCC cell lines.
Main Methods:
- Survival analysis using clinical data and tissue microarrays for IGF1R expression.
- In vitro assays including immunoblotting, proliferation, viability, clonogenic survival, flow cytometry, and reverse phase protein array (RPPA) to assess drug responses.
Main Results:
- Increased IGF1R expression was linked to reduced 5-year survival in stage III/IV oral cavity squamous cell carcinoma (OCSCC) patients (P=0.029).
- Both OSI-906 and BMS-754807 inhibited IGF1R and Akt phosphorylation and proliferation in HNSCC cells; BMS-754807 demonstrated greater potency.
- Both TKIs reduced HNSCC cell viability, with OSI-906 achieving complete cell elimination at 10 μM. RPPA revealed broad pathway inhibition, including HER3, Src, paxillin, and ezrin phosphorylation.
Conclusions:
- OSI-906 and BMS-754807 effectively inhibit IGF1R activity in HNSCC cell lines, reducing pro-survival signaling.
- These IGF1R antagonists exhibit antiproliferative and proapoptotic effects, suggesting potential as adjuvant therapies for HNSCC.
More Related Videos
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Insulin: The Receptor and Signaling Pathways
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Influencing Microbial Growth: pH
Factors Influencing Microbial Growth: Temperature

